Kodak exploded overnight 13 times. How to treat Kodak's stock price soaring after it entered the pharmaceutical industry?

Kodak, the film king, is a cross-border pharmaceutical company. It is inevitable that the stock price will skyrocket. Kodak used to be a huge industrial giant, with a considerable number of patented technologies and experience in operating pharmaceutical companies. Kodak's move is to respond to the social needs of anti-epidemic, and has received financial support from the government, which can transform production capacity in time. This former corporate giant once again stood at the forefront of the development of the times.

On July 28th, Kodak announced that it had obtained a $765 million government loan to produce generic drugs including hydroxychloroquine. This drug has some effect in treating new crowns, but The Lancet revealed that it will accelerate the death of patients. Kodak plans to use the above loans to set up a pharmaceutical department to produce essential pharmaceutical ingredients that have been in short supply in the United States for a long time, so as to reduce the dependence of the United States on imported drugs.

On July 29th, Kodak triggered the fuse as high as 10 times, then it soared and then plunged, and quickly fell back from the increase of 572% to 260%, thus triggering the 13 fuse of the stock that day. On that day, Kodak's share price closed at $32.92/share, up 3 14.6%. After several days of soaring, Kodak's share price closed at $265,438+0.85 per share at 4 pm on July 365,438+0. The cumulative increase in the last five trading days was 940.48%.

Kodak was born in 1892. As a former king of film, a pioneer in the global photography industry and a huge industrial giant, Apple is much better than Google today. As one of the largest industrial manufacturing enterprises in the world, it has a large number of patented technologies from chemistry to manufacturing. Even if it goes bankrupt, the market valuation is not high, but it still has a very strong enterprise foundation, which is also very broad for the market, and the future development potential must be huge.

12 After Kodak filed for bankruptcy protection, 13 Kodak embarked on the road of cross-border transformation. It founded fashion magazines, developed mobile phones and established pharmaceutical companies with relevant business experience. Most importantly, it has a number of patented technologies in the chemical field, and pharmaceutical manufacturing R&D is a branch of chemical engineering and technology, which will be an important driving force for the development of Kodak Pharmaceutical Company.